This study asks whether a 7-day course of oral antibiotics after discharge lowers the 1-year periprosthetic joint infection rate in high-risk hip and knee arthroplasty patients. It is a single-institution retrospective cohort of 3855 consecutive primary THAs and TKAs, comparing high-risk patients who did and did not receive extended prophylaxis.
When you see a high-risk arthroplasty candidate (obese, diabetic, smoker, MRSA/MSSA colonized, or on immunosuppression), this paper gives you a concrete tool: a 7-day oral antibiotic course at discharge.
The mental model the authors use is the "golden period" — the first 6 hours after surgery when host defenses hold bacteria in check. Extended oral antibiotics prolong that window for patients whose host factors are otherwise hard to optimize.
The striking result is that treated high-risk patients had an infection rate no different from low-risk patients. This matters for boards: host optimization is difficult, and there is limited evidence that preoperative measures like weight loss alone lower PJI.
Weigh the evidence appropriately. This is a Level III single-institution retrospective study; selection across calendar-defined groups and antimicrobial-resistance concerns are real limitations. The authors explicitly call for a multicenter RCT before universal adoption.
For exam purposes, anchor the baseline PJI rate at 1%-2%, MSIS diagnostic criteria, and the modifiable risk factors that define a high-risk host.
This study asks whether a 7-day course of oral antibiotics after discharge lowers the 1-year periprosthetic joint infection rate in high-risk hip and knee arthroplasty patients. It is a single-institution retrospective cohort of 3855 consecutive primary THAs and TKAs, comparing high-risk patients who did and did not receive extended prophylaxis.
When you see a high-risk arthroplasty candidate (obese, diabetic, smoker, MRSA/MSSA colonized, or on immunosuppression), this paper gives you a concrete tool: a 7-day oral antibiotic course at discharge.
The mental model the authors use is the "golden period" — the first 6 hours after surgery when host defenses hold bacteria in check. Extended oral antibiotics prolong that window for patients whose host factors are otherwise hard to optimize.
The striking result is that treated high-risk patients had an infection rate no different from low-risk patients. This matters for boards: host optimization is difficult, and there is limited evidence that preoperative measures like weight loss alone lower PJI.
Weigh the evidence appropriately. This is a Level III single-institution retrospective study; selection across calendar-defined groups and antimicrobial-resistance concerns are real limitations. The authors explicitly call for a multicenter RCT before universal adoption.
For exam purposes, anchor the baseline PJI rate at 1%-2%, MSIS diagnostic criteria, and the modifiable risk factors that define a high-risk host.